Success Metrics

Clinical Success Rate
70.0%

Based on 7 completed trials

Completion Rate
70%(7/10)
Active Trials
0(0%)
Results Posted
29%(2 trials)
Terminated
3(27%)

Phase Distribution

Ph phase_1
7
64%
Ph phase_2
4
36%

Phase Distribution

7

Early Stage

4

Mid Stage

0

Late Stage

Phase Distribution11 total trials
Phase 1Safety & dosage
7(63.6%)
Phase 2Efficacy & side effects
4(36.4%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

63.6%

7 of 11 finished

Non-Completion Rate

36.4%

4 ended early

Currently Active

0

trials recruiting

Total Trials

11

all time

Status Distribution
Completed(7)
Terminated(4)

Detailed Status

Completed7
Terminated3
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
0
Success Rate
70.0%
Most Advanced
Phase 2

Trials by Phase

Phase 17 (63.6%)
Phase 24 (36.4%)

Trials by Status

terminated327%
completed764%
withdrawn19%

Recent Activity

0 active trials
Showing 5 of 11
completedphase_1

A Study To Estimate The Effect Of Repeated Dosing of PF-05175157 On The Pharmacokinetics Of A Single Dose Of Simvastatin In Healthy Adult Subjects

NCT01469468
terminatedphase_2

A 6-Week Study Of PF-05175157 In Type 2 Diabetes Mellitus

NCT01792635
terminatedphase_2

A 6-Week Study To Determine The Safety And Effect Of An Investigational Drug Given With Canagliflozin In Adults With Type 2 Diabetes Mellitus Taking Metformin

NCT02053116
terminatedphase_2

A 6-Week Study To Determine The Safety And Effect Of An Investigational Drug On Adults With Type 2 Diabetes Mellitus Taking Metformin

NCT02053103
completedphase_1

Effect Of Single-Dose PF-05175157 On Metabolic And Cardiopulmonary Parameters

NCT01819922
View all 11 trials

Clinical Trials (11)

Showing 11 of 11 trials
NCT01469468Phase 1

A Study To Estimate The Effect Of Repeated Dosing of PF-05175157 On The Pharmacokinetics Of A Single Dose Of Simvastatin In Healthy Adult Subjects

Completed
NCT01792635Phase 2

A 6-Week Study Of PF-05175157 In Type 2 Diabetes Mellitus

Terminated
NCT02053116Phase 2

A 6-Week Study To Determine The Safety And Effect Of An Investigational Drug Given With Canagliflozin In Adults With Type 2 Diabetes Mellitus Taking Metformin

Terminated
NCT02053103Phase 2

A 6-Week Study To Determine The Safety And Effect Of An Investigational Drug On Adults With Type 2 Diabetes Mellitus Taking Metformin

Terminated
NCT01819922Phase 1

Effect Of Single-Dose PF-05175157 On Metabolic And Cardiopulmonary Parameters

Completed
NCT02100527Phase 2

Study Of Safety, Tolerability And Effects Of PF-05175157 In Adults With Moderate To Severe Acne Vulgaris

Withdrawn
NCT01807377Phase 1

Multiple Dose Safety Tolerability, Pharmacokinetics And Midazolam Interaction In Healthy Overweight And Obese Subjects

Completed
NCT01821079Phase 1

A Healthy Volunteer Study To Assess Relative Bioavailability Of Powder-In-Capsule And A Tablet Formulation And The Effect Of Food On The Pharmacokinetics Of The Tablet Formulation

Completed
NCT01757756Phase 1

Multiple Dose Safety Toelrability, Pharmacokinetics and Midazolam Interaction In Healthy Overweight And Obese Subjects

Completed
NCT01537497Phase 1

A Study To Evaluate The Effects Of PF-05175157 In Healthy Volunteers

Completed
NCT01433380Phase 1

A Study To Evaluate PF-05175157 In Healthy Volunteers

Completed

All 11 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
11